(Q39191315)

9 September 2017

title

No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations (English)

1 reference

9 September 2017

0 references

anti-retroviral agent

0 references

1

Selwyn H Lowe

1 reference

9 September 2017

8

Joep M A Lange

1 reference

9 September 2017

author name string

Annemarie M J Wensing

2

1 reference

9 September 2017

Jacqueline A H Droste

3

1 reference

9 September 2017

Reinier W ten Kate

4

1 reference

9 September 2017

Suzanne Jurriaans

5

1 reference

9 September 2017

David M Burger

6

1 reference

9 September 2017

Jan C C Borleffs

7

1 reference

9 September 2017

Jan M Prins

9

1 reference

9 September 2017

publication date

1 November 2006

1 reference

9 September 2017

1 reference

9 September 2017

volume

7

1 reference

9 September 2017

issue

6

1 reference

9 September 2017

page(s)

285-290

1 reference

Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Antiretroviral treatment of central nervous system HIV-1 infection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Viruses in the mammalian male genital tract and their effects on the reproductive system

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Human immunodeficiency virus type-1 episomal cDNA in semen

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

HIV in semen: still more to be learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

Poor penetration of the male genital tract by HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0706-285

21 January 2018

Identifiers

DOI

10.1310/HCT0706-285

1 reference

9 September 2017

1 reference